Patent details

EP2805723 Title: Cladribine regimen for treating multiple sclerosis

Basic Information

Publication number:
EP2805723
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP140019704
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Cladribine regimen for treating multiple sclerosis
French Title of Invention:
Régime posologique de cladribine pour le traitement de la sclérose en plaques
German Title of Invention:
Cladribin Dosierschema zur Behandlung von multipler Sklerose
SPC Number:
LUC00064

Dates

Filing date:
20/12/2005
Grant date:
17/01/2018
EP Publication Date:
26/11/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/01/2018
EP B1 Publication Date:
17/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/12/2025
Renunciation date:
Revocation date:
12/09/2023
Annulment date:

Owner

From:
10/01/2018
 
 

Name:
Merck Serono SA
Address:
Centre Industriel, 1267 Coinsins, Vaud, Switzerland (CH)

Inventor

1

Name:
Munafo, Alain
Address:
Switzerland (CH)

2

Name:
Lopez-Bresnahan, Maria
Address:
United States (US)

3

Name:
Ythier, Arnaud
Address:
Switzerland (CH)

4

Name:
De Luca, Giampiero
Address:
Switzerland (CH)

Priority

1

Priority Number:
638669 P
Priority Date:
22/12/2004
Priority Country:
United States (US)

2

Priority Number:
04106909
Priority Date:
22/12/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/20; A61K 31/7076; A61K 38/21; A61P 25/00;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2023/13
Publication date:
07/12/2023
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201803
Publication date:
17/01/2018
Description:
Grant (B1)

2

Issue number:
201847
Publication date:
21/11/2018
Description:
Opposition procedure started

3

Issue number:
202347
Publication date:
22/11/2023
Description:
Revocation of the European patent

4

Issue number:
201808
Publication date:
21/02/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/12/2022
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages